Phil Hathaway
A16z Capital Management, L.l.c.
Assets Managed
$1.291B
Holdings
16
Last Quarter
2026 - Q1
Filed Date
21d ago
Growth Rate
-18.3%(2Q avg: -2.52%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in A16z Capital Management, L.l.c.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 16 positions.
Assets under management
The assets under management (AUM) of A16z Capital Management, L.l.c. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.291B in assets, with a quarterly growth rate of -18.3% and a 2-quarter average growth rate of -2.52%. The portfolio is managed by Phil Hathaway, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
NAVN Navan Inc-cl A
| 28.95% | $373.615M 28.219M shares@ $13.24 avg price | Increased 3.77% |
FIG Figma Inc-cl A
| 26.23% | $338.481M 16.011M shares@ $21.15 avg price | Decreased -1.44% |
META Meta Platforms Inc-class A
| 9.43% | $121.595M 212,531 shares@ $572.13 avg price | |
RVMD Revolution Medicines Inc
| 6.95% | $89.577M 921,099 shares@ $97.26 avg price | |
NAUT Nautilus Biotechnology Inc
| 5.31% | $68.497M 17.654M shares@ $3.89 avg price | |
SQ Block Inc
| 4.75% | $61.185M 1.017M shares@ $60.18 avg price | |
BIOA Bioage Labs Inc
| 4.39% | $56.548M 3.233M shares@ $17.49 avg price | |
MAZE Maze Therapeutics Inc
| 3.94% | $50.811M 1.702M shares@ $29.85 avg price | |
ERAS Erasca Inc
| 3.59% | $46.315M 2.863M shares@ $16.18 avg price | |
GLTO Galecto Inc
| 2.49% | $32.016M 1.236M shares@ $25.9 avg price | New Position |
1-10 of 16